Rheumatology Flashcards
large vessel vasculitides
takayasu arteritis
giant cell arteritis
medium vessel vasculitides
polyarteritis nodosa
kawasaki disease
small vessel vasculitides
ANCA-associated
microscopic polyangiitis
granulomatous with polyangiitis (wegeners)
eosinophilic granulomatosis with polyangiitis (churg strauss)
immune complex
cryoglobulinaemic vasculitis
IgA vasculitis (henoch schonlein)
anti C1q vasculitis
features of giant cell arteritis
most common form of systemic vasculitis - granulomatous arteritis of aorta + major branches, affects extracranial branches of carotid esp temporal artery
assx with polymyalgia rheumatics
pathophysiology of giant cell arteritis
dendritic cells recruit CD4+ cells and activate macrophages which destory internal elastic lamina causing granuloma and giant cell formation
causes thickening and focal lesions - may or not be picked up by temporal artery biopsy
symptoms of giant cell arteritis
involvement of cranial nerves - headache, jaw claudication, scalp tenderness, loss of vision
involvement of great vessels - arm claudication
systemic inflammation - fever night sweats weight loss
PMR - proximal myalgua
examination findings of giant cell arteritis
tender/thickened/nodular temporal artery
scalp tenderness
proximal muscle weakness
visual loss - ?examine visual acuity - due to anterior ischaemic optic neuropathy
investigation findings in giant cell arteritis
ESR, CRP +++
fundoscopy /slit lamp - refer to ophthal
US temporal artery - halo sign
temporal artery biopsy
FDG PET scan - assesses disease activity
management of giant cell arteritis
high dose steroids - medical emergency
with ocular sx - IV methylprednisolone
no ocular sx - PO pred
if relapsing - methotrexate
add tocilizumab if risk of steroid toxicity
features of polymyalgia rheumatics
inflammatory condition of elderly women >50y characterised by proximal limb girdle weakness
non specifically unwell
stiffness
fever, weight loss, fatigue
bursitis/synovitis
investigation findings for polymyalgia rheumatica
high ESR/CRP
broad panel of bloods due to vague presentation - myeloma screen, RH, CCP, renal, bone
management of polymyalgia rheumatica
steroids - prednisolone 15mg/day - should respond <48h - reconsider diagnosis if not
PPI and bone protection
definition of takayasu arteritis
granulomatous inflammation of aorta and major branches
subclavian artery - arm claudication
renal artery - hypertension
carotid artery - CNS features
occurs in <40y F, asian
rare
pathophysiology of takayasu
granulomatous necrotising vasculitis affecting large vessels – adventitial thickening, infiltration of media, fibrosis of intima and thus stenosis
dilatation – aneurysms
can be local or widespread inflammation
commonly starts at L subclavian artery
genetic+ environmental
features of takayasu arteritis
absent peripheral pulses
claudication of extremities
transient visual disturbance - amaurosis fugax
TIAs, CVAs - young people with high inflammatory markers
syncope - subclavian steal
BP difference between arms
bruits
weight loss, myalgia, sweats
investigation findings of takayasu arteritis
ESR, CRP ++
MRA, CTA - imaging aorta and arterial tree
USS doppler of carotid and subclavian
PET
management of takayasu arteritis
high dose steroid and methotrexate (if steroid sparing agent needed)
steroid sparing immunosuppression long term - cyclophosphamide
biologics
endovascular interventions e.g., stenting
serial MRA
definition of polyarteritis nodosa
necrotising inflammation of medium-sized arteries (GI, renal, coronary)
assx hepatitis B
occurs in males 60s
investigation of polyarteritis nodosa
urinalysis
uPCR
bloods - raised inf markers
hep serology
skin biopsy
nerve conduction studies
angiography
seronegative
management of polyarteritis nodosa
mild - oral steroids
systemic - IV steroids, IV cyclophosphamide
if HBV + - treat with antiviral treatment
what are the ANCA associated vasculitides
small vessel vasculitides
granulomatosis with polyangiitis (Wegeners)
eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
microscopic polyangiitis
common features in ANCA associated vasculitides
renal impairment - due to immune complex glomerulonephritis causing raised creatinine, haematuria, proteinuria
respiratory symptoms - dyspnoea, haemoptysis
systemic sx - fatigue, weight loss, fever
vasculitis rash
ENT sx - sinusitis
the two types of ANCA
cANCA - granulomatosis with polyangiitis
cANCA levels related to disease activity
pANCA - eosinophilic granulomatosis with polyangiitis + microscopic polyangiitis, UC, PSC, anti GBC disease, Crohns
pANCA levels unrelated to disease activity
features of ankylosing spondylitis
HLA-B27 associated spondyloarthropathy presenting in males 20-30y
lower back pain and stiffness (worse in morning, improves with exercise)
pain at night
7As
Apical fibrosis
Anterior uveitis
Aortic regurgitation
Achilles tendonitis
AV node block
Amyloidosis
and cauda equina syndrome
peripheral arthritis (25%, more common if female)
clinical examination findings in ankylosing spondylitis
reduced lateral flexion
reduced forward flexion - schober’s test
reduced chest expansion
investigation findings in ankylosing spondylitis
XR - sacroiliitis (subchondral erosions, sclerosis), squaring of lumbar vertebrae, bamboo spine, syndesmophytes
CXR - apical fibrosis
MRI - early inflammation of sacroiliac joints - bone marrow oedema
spirometry - restrictive defect
management of ankylosing spondylitis
regular exercise
NSAIDs
physiotherapy
DMARDs - useful if peripheral joint involvement
anti TNF if refractory high disease activity
definition of antiphospholipid syndrome
acquired disorder - predisposition to venous and arterial thrombosis, foetal loss, thrombocytopenia
may be primary disorder or secondary (e.g., SLE)
features of antiphospholipid syndrome
venous/arterial thrombosis
recurrent miscarriages
livedo reticularis
other features: pre-eclampsia, pulmonary hypertension
investigation findings in antiphospholipid syndrome
antibodies
anticardiolipin antibodies
anti-beta2 glycoprotein I (anti-beta2GPI) antibodies
lupus anticoagulant
thrombocytopenia
prolonged APTT
management of antiphospholipid syndrome
primary thromboprophylaxis - low dose aspirin
secondary thromboprophylaxis
after initial event - lifelong warfarin INR 2-3
recurrent - lifelong warfarin +/- low dose aspirin, INR 3-4
overview of antisynthetase syndrome
aused by autoantibodies against aminoacyl-tRNA synthetase e.g. anti-Jo1.
It is characterised by
myositis
interstitial lung disease
thickened and cracked skin of the hands (mechanic’s hands)
Raynaud’s phenomenon
moa and S/E of azathioprine
inhibits purine synthesis
TPMT test before commencing drug
Adverse effects include
bone marrow depression
consider a full blood count if infection/bleeding occurs
nausea/vomiting
pancreatitis
increased risk of non-melanoma skin cancer
C/I with allopurinol - use lower doses
safe in pregnancy
definition of behcet’s syndrome
autoimmune inflammation of arteries and veins
more common in men, 20-40y
triad of sx - oral ulcers, genital ulcers and anterior uveitis
assx HLA B51
clinical diagnosis
features of behcet’s syndrome
1) oral ulcers 2) genital ulcers 3) anterior uveitis
thrombophlebitis and deep vein thrombosis
arthritis
neurological involvement (e.g. aseptic meningitis)
GI: abdo pain, diarrhoea, colitis
erythema nodosum
use and moa of bisphosphonates
inhibits osteoclasts by reducing recruitment and promoting apoptosis
Clinical uses
prevention and treatment of osteoporosis
hypercalcaemia
Paget’s disease
pain from bone metatases
correct hypocalcaemia/VD before giving bisphosphonates
adverse effects of bisphosphonates
oesophageal reactions: oesophagitis, oesophageal ulcers
osteonecrosis of the jaw
increased risk of atypical stress fracture
acute phase response - fever, myalgia and arthralgia
hypocalcaemia - due to reduced calcium efflux from bone
lab values of osteoporosis
calcium
phosphate
ALP
PTH
all normal
lab values of osteomalacia
calcium -
phosphate -
ALP +
PTH +
primary hyperparathyroidism
calcium +
phosphate -
ALP +
PTH +
lab values (bone) of chronic kidney disease
calcium -
phosphate +
ALP +
PTH +
lab values of paget’s disease
calcium
phosphate
ALP +
PTH
lab values of osteopetrosis
calcium
phosphate
ALP
PTH
all normal
features of osteochondroma
most common benign bone tumour
more in males, usually diagnosed in patients aged < 20 years
cartilage-capped bony projection on the external surface of a bone
features of osteoma
benign ‘overgrowth’ of bone, most typically occuring on the skull
associated with Gardner’s syndrome (a variant of familial adenomatous polyposis, FAP)
features of osteosarcoma
most common primary malignant bone tumour
affects children and adolescents
occurs most frequently in the metaphyseal region of long bones prior to epiphyseal closure - femur, tibia, humerus
x-ray shows Codman triangle (from periosteal elevation)
‘sunburst’ pattern
assx with Rb gene mutation
other predisposing factors include Paget’s disease of the bone and radiotherapy
features of ewing’s sarcoma
small round blue cell tumour in children and adolescents
occurs in pelvis and long bones
causes severe pain
onion skin appearance
features of chondrosarcoma
malignant tumour of cartilage
most commonly affects the axial skeleton
more common in middle-age
features of chronic fatigue syndrome
sleep problems, such as insomnia, hypersomnia, unrefreshing sleep, a disturbed sleep-wake cycle
muscle and/or joint pains
headaches
painful lymph nodes without enlargement
sore throat
cognitive dysfunction, such as difficulty thinking, inability to concentrate, impairment of short-term memory, and difficulties with word-finding
physical or mental exertion makes symptoms worse
general malaise or ‘flu-like’ symptoms
definition of chronic fatigue syndrome
at least 3 months of disabling fatigue affecting mental and physical function more than 50% of the time in the absence of other disease which may explain symptoms
more common in females
managing chronic fatigue syndrome
physical activity and exercise - overseen by ME/CFS team
supportive CBT
causes of dactylitis
Dactylitis describes the inflammation of a digit (finger or toe).
Causes include:
spondyloarthritis: e.g. Psoriatic and reactive arthritis
sickle-cell disease
other rare causes include tuberculosis, sarcoidosis and syphilis
overview of dermatomyositis
inflammatory disorder causing symmetrical proximal muscle weakness and skin lesions
idiopathic / connective tissue disorders / underlying malignancy
features of dermatomyositis
skin - photosensitive, macular rash (back and shoulder), periorbital heliotrope rash, gottron’s papules (on extensor surface of fingers), dry and scaly hands
proximal muscle weakness +/- tenderness
Raynaud’s
respiratory muscle weakness
interstitial lung disease: e.g. Fibrosing alveolitis or organising pneumonia
dysphagia, dysphonia
investigation findings in dermatomyositis
ANA positive
features of discoid lupus erythematosus
benign autoimmune disorder of younger females - rarely progresses to SLE
follicular keratin plugs
erythematous rash, scaly - on face, neck, ears, scalp
photosensitive
lesions heal with atrophy, scarring, pigmentation
management of discoid lupus erythematosus
topical steroids
oral anti malarials
avoid sun exposure
features of drug induced lupus
arthralgia
myalgia
skin (e.g. malar rash) and pulmonary involvement (e.g. pleurisy) are common
ANA positive
anti-histone antibodies are found in 80-90%
anti-Ro, anti-Smith positive in around 5%
causes of drug induced lupus
procainamide
hydralazine
less common
isoniazid
minocycline
phenytoin
features of ehler-danlos
autosomal dominant connective tissue disorder of type III collagen
tissue is more elastic – joint hypermobility and increased skin elasticity (fragile)
recurrent dislocation
easy bruising
aortic regurg, mitral valve prolapse, aortic dissection
subarachnoid haemorrhage
features of fibromyalgia
widespread pain with tender points at specific anatomical sites
chronic pain: at multiple site, sometimes ‘pain all over’
lethargy
cognitive impairment: ‘fibro fog’
sleep disturbance, headaches, dizziness are common
management of fibromyalgia
explanation
aerobic exercise: has the strongest evidence base
cognitive behavioural therapy
medication: pregabalin, duloxetine, amitriptyline
features of gout
flares - few days, sx free between episodes
pain, swelling erythema
affects 1st MTP, ankle, wrist, knee
can cause joint damage and chronic problems
investigation findings of gout
synovial fluid analysis
needle shaped negatively birefringent monosodium urate crystals under polarised light
uric acid - check >2w when acute episode has settled - may vary during attack
radiological features
joint effusion
punched out erosions with sclerotic margins
joint space preserved
no periarticular osteopenia
soft tissue tophi
management of acute gout
NSAIDs, colchicine
prescribe max NSAID dose until 1-2days after sx settle
PPI
colchicine - slower onset of action, use with caution if renal impairment - may cause diarrhoea
oral steroids if ^ C/I - 15mg/day prednisolone
intraarticular steroid injection
if already on allopurinol - continue
indications for urate lowering therapy
indicated after first attack
allopurinol - 100mg od, titrate dose every few weeks
febuxostat - if allopurinol is not tolerated
if refractory - uricase
conservative management of gout
reduce alcohol intake and avoid during an acute attack
lose weight if obese
avoid food high in purines
stop precipitants e.g., thiaxides
predisposing factors for gout
microcrystal synovitis caused by the deposition of monosodium urate monohydrate in the synovium due to chronic hyperuricaemia - uric acid >0.45mmol/l
reduced uric acid excretion - diuretics, CKD, lead toxicity
increased uric acid production - myeloproliferative disorder, cytotoxic drugs, severe psoriasis
lesch-nyhan syndrome -
causes of hip pain in adults
osteoarthritis
inflammatory arthritis
referred lumbar spine pain
greater trochanteric pain syndrome
meralgia paraesthetica
avascular necrosis
pubic symphysis dysfunction
transient idiopathic osteoporosis c
HLA-B51
Behcet’s disease
HLA-B27
ankylosing spondylitis
reactive arthritis
acute anterior uveitis
psoriatic arthritis
HLA-DQ2/DQ8
coeliac disease
HLA-DR2
narcolepsy
Goodpasture’s
HLA-DR3
dermatitis herpetiformis
Sjogren’s syndrome
primary biliary cirrhosis
HLA DR4
type 1 diabetes mellitus*
rheumatoid arthritis - in particular the DRB1 gene (DRB104:01 and DRB104:04 hence the association with DR4)